Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125159) titled 'Nanocrystalline Megestrol Acetate Oral Suspension for the Treatment of Cancer Anorexia-Cachexia Syndrome in Advanced Non-Small Cell Lung Cancer: A Randomized, Controlled, Multicenter Study' on May 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Chinese PLA General Hospital
Condition:
cancer anorexia-cachexia syndrome
Intervention:
Treatment group :Nanocrystalline Megestrol Acetate Oral Suspension (5ml, QD, up to 12 weeks starting from immunotherapy)+PD - (L) 1 inhibitor (Q3W, up to PD)+chemotherapy regimen
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: ...